These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28082032)

  • 41. Performance of the 2010 classification criteria for rheumatoid arthritis: a systematic literature review and a meta-analysis.
    Sakellariou G; Scirè CA; Zambon A; Caporali R; Montecucco C
    PLoS One; 2013; 8(2):e56528. PubMed ID: 23437156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
    Liu L; Liu S; Wang C; Guan W; Zhang Y; Hu W; Zhang L; He Y; Lu J; Li T; Liu X; Xuan Y; Wang P
    J Clin Rheumatol; 2019 Aug; 25(5):197-202. PubMed ID: 29975207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases.
    Furst DE
    Br J Rheumatol; 1997 Nov; 36(11):1196-204. PubMed ID: 9402864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
    Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimizing methotrexate therapy in rheumatoid arthritis: a systematic literature review.
    Mouterde G; Baillet A; Gaujoux-Viala C; Cantagrel A; Wendling D; Le Loët X; Schaeverbeke T
    Joint Bone Spine; 2011 Dec; 78(6):587-92. PubMed ID: 21444233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.
    Barrera P; van der Maas A; van Ede AE; Kiemeney BA; Laan RF; van de Putte LB; van Riel PL
    Rheumatology (Oxford); 2002 Apr; 41(4):430-9. PubMed ID: 11961174
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
    Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
    Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.
    Simpson EL; Ren S; Hock ES; Stevens JW; Binard A; Pers YM; Archer R; Paisley S; Stevenson MD; Herpin C; Ghabri S
    Int J Technol Assess Health Care; 2019 Jan; 35(1):36-44. PubMed ID: 30722803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Meta-analysis of RCT studies on clinical efficacy of single administration of Tripterygium Glycosides Tablets or combined administration with methotrexate against rheumatoid arthritis].
    Chen WJ; Li TX; Wang XY; Xue ZP; Lyu C; Li HZ; Li YQ; Fan YF; Tian YG; Yang J; Guo MQ; Wang JX; Wu HY; Zhang YQ; Lin N
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(4):791-797. PubMed ID: 32237478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative Assessment of the Different American College of Rheumatology/European League Against Rheumatism Remission Definitions for Rheumatoid Arthritis for Their Use as Clinical Trial End Points.
    Mack ME; Hsia E; Aletaha D
    Arthritis Rheumatol; 2017 Mar; 69(3):518-528. PubMed ID: 27696724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.
    Stamp LK; Roberts RL
    Pharmacogenomics; 2011 Oct; 12(10):1449-63. PubMed ID: 22008049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ].
    Martín Mola E; Hernández B; García-Arias M; Alvaro-Gracia JM; Balsa A; Reino JG; Marenco de la Fuente JL; Martínez-Taboada V; Ivorra JA; Sanmartí R;
    Reumatol Clin; 2011; 7(1):30-44. PubMed ID: 21794777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methotrexate: a gold standard for treatment of rheumatoid arthritis.
    Shinde CG; Venkatesh MP; Kumar TM; Shivakumar HG
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):351-8. PubMed ID: 25322199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Jobanputra P; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Kynaston-Pearson FJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD007649. PubMed ID: 25231904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
    Gaujoux-Viala C; Rincheval N; Dougados M; Combe B; Fautrel B
    Ann Rheum Dis; 2017 Dec; 76(12):2054-2060. PubMed ID: 28866645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Landmark papers on the discovery of methotrexate for the treatment of rheumatoid arthritis and other systemic inflammatory rheumatic diseases: a fascinating story.
    Malaviya AN
    Int J Rheum Dis; 2016 Sep; 19(9):844-51. PubMed ID: 27293066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methotrexate in rheumatoid arthritis.
    Swierkot J; Szechiński J
    Pharmacol Rep; 2006; 58(4):473-92. PubMed ID: 16963793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.